Diluents and multi-dose vials
- Bacteriostatic water composition (0.9% benzyl alcohol) and labeling: DailyMed: bacteriostatic water labels
- Multi-dose vial handling and the common 28-day discard guidance: CDC: Injection Safety
Syringes and units
- U-100 vs U-40 insulin concentration standards: DailyMed: U-100 insulin labels and DailyMed: insulin syringe labeling
Compound status (as stated on peptide chart pages)
| Compound | Source |
|---|---|
| Semaglutide | FDA label (DailyMed) · PubMed |
| Tirzepatide | FDA label (DailyMed) · PubMed |
| Retatrutide | ClinicalTrials.gov · PubMed |
| Cagrilintide | ClinicalTrials.gov · PubMed |
| BPC-157 | Drugs@FDA (no approval listed) · PubMed |
| TB-500 | Drugs@FDA (no approval listed) · PubMed |
| GHK-Cu | Drugs@FDA (no approval listed) · PubMed |
| Ipamorelin | Drugs@FDA (no approval listed) · PubMed |
| CJC-1295 | Drugs@FDA (no approval listed) · PubMed |
| Tesamorelin | FDA label (DailyMed) · PubMed |
| MOTS-c | Drugs@FDA (no approval listed) · PubMed |
| Thymosin Alpha-1 | Drugs@FDA (no approval listed) · PubMed |
Regulatory status can change. If you spot something out of date, it'll be corrected at the next review.
Last reviewed 2026-11-17 · How we check · Sources